玻璃体腔注射曲安奈德治疗脉络膜新生血管膜的疗效观察

Clinical observation on the intravitreal triamcinolone acetonide for treating choroidal neovascularization

下载PDF

导出

作者李付亮阴正勤孟晓红

机构地区第三军医大学西南医院全军眼科中心

出处《第三军医大学学报》 CAS CSCD 北大核心 2004年第5期460-462,共3页 Journal of Third Military Medical University

关键词玻璃体腔注射曲安奈德治疗脉络膜新生血管膜疗效观察

参考文献5

1[1]Danis R P, Ciulla T A, Pratt L M, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration[J]. Retina, 2000, 20(3): 244-250.
2[2]Kivilcim M, Peyman G A, El-Dessouky E S, et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes[J]. Ophthalmic Surg Lasers, 2000, 31(6): 474-478.
3[3]Ciulla T A, Criswell M H, Danis R P, et al. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants[J]. Br J Ophthalmol, 2003, 87(8): 1032-1037.
4[4]Spaide R F, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization[J]. Ophthalmology, 2003, 110(8): 1517-1525.
5[5]Penfold P L, Wen L, Madigan M C. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration[J]. Clin Exp Immunol, 2000, 121(3): 458-465.

第三军医大学学报

2004年第5期

内容加载中请稍等...